Why the study?
Does screening for aneurysms every 5 years improve life expectancy, QALYs, and costs in patients who survived subarachnoid hemorrhage?
Does screening for aneurysms every 5 years improve life expectancy, QALYs, and costs in patients who survived subarachnoid hemorrhage?
Routine screening for aneurysms every 5 years after subarachnoid hemorrhage is not generally recommended as it reduces QALYs and increases costs, though it may benefit high-risk patients or those with significant fear of recurrence.
No takes yet. Share an insight, caveat, or question.
Does not support routine post-SAH aneurysm screening; leaves open targeted use in high-risk subgroups for further study.
Wermer et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: